Screener
Bio-Rad Laboratories BIO Cash Flow Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $98.7M-15.3% | $108.1M-16.8% | $164.9M+32.8% | $120.9M-26.1% | $116.5M+19.4% | ||
| $32M-30.0% | $30M-12.8% | $45.8M+6.8% | $31.7M-21.1% | $45.7M+8.0% | ||
| -$66.7M+42.2% | -$93.2M-3,314% | -$34.2M-12.1% | -$43M+22.8% | -$115.4M-273% | ||
| $31.5M-77.5% | $47.8M-53.1% | $0— | $53.4M-45.5% | $140.2M+38.8% | ||
| $200K0.0% | $100K0.0% | $0— | —— | $200K+100% | ||
| -$27.6M+79.8% | -$44M+55.0% | $0+100% | -$52.5M+45.3% | -$136.3M-41.1% | ||
| —— | -$23.2M-170% | $26.5M-65.9% | —— | -$151.4M— | ||
| $66.7M-5.8% | $78.1M-18.2% | $119.1M+46.5% | $89.2M-27.7% | $70.8M+28.0% |
FAQ
- How much cash does Bio-Rad Laboratories generate?
- Bio-Rad Laboratories (BIO) generated $492.6M in operating cash flow over the trailing twelve months.
- What is Bio-Rad Laboratories's free cash flow?
- After $139.5M of capital expenditures, Bio-Rad Laboratories's free cash flow was $353.1M over the trailing twelve months, down 4.8% year over year.
- Where does Bio-Rad Laboratories's cash flow data come from?
- Every line is extracted from Bio-Rad Laboratories's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
